Abstract
Advances in molecular biology and the new genetics are opening up new routes to the development of safer and more effective vaccines. At the molecular level we are beginning to understand how the host immune defences and the invading pathogen interact. Important protective components are being identified, new methods for attenuating virulent pathogens are being applied, and alternative routes for antigen presentation are being exploited. One goal may be the development of the totally synthetic vaccine. The progress in this area and the implications for the future are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 393-398 |
| Number of pages | 6 |
| Journal | Medical Laboratory Sciences |
| Volume | 42 |
| Issue number | 4 |
| Publication status | Published - 1 Dec 1985 |
| Externally published | Yes |
Cite this
}
Molecular biology, the new genetics and vaccine development. / Dougan, G.; Highfield, P.
In: Medical Laboratory Sciences, Vol. 42, No. 4, 01.12.1985, p. 393-398.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Molecular biology, the new genetics and vaccine development
AU - Dougan, G.
AU - Highfield, P.
PY - 1985/12/1
Y1 - 1985/12/1
N2 - Advances in molecular biology and the new genetics are opening up new routes to the development of safer and more effective vaccines. At the molecular level we are beginning to understand how the host immune defences and the invading pathogen interact. Important protective components are being identified, new methods for attenuating virulent pathogens are being applied, and alternative routes for antigen presentation are being exploited. One goal may be the development of the totally synthetic vaccine. The progress in this area and the implications for the future are discussed.
AB - Advances in molecular biology and the new genetics are opening up new routes to the development of safer and more effective vaccines. At the molecular level we are beginning to understand how the host immune defences and the invading pathogen interact. Important protective components are being identified, new methods for attenuating virulent pathogens are being applied, and alternative routes for antigen presentation are being exploited. One goal may be the development of the totally synthetic vaccine. The progress in this area and the implications for the future are discussed.
UR - http://www.scopus.com/inward/record.url?scp=0022385778&partnerID=8YFLogxK
M3 - Article
VL - 42
SP - 393
EP - 398
JO - Medical Laboratory Sciences
JF - Medical Laboratory Sciences
SN - 0308-3616
IS - 4
ER -